Raymond James Financial’s Nuvalent NUVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.54M Sell
20,584
-124,704
-86% -$13.4M ﹤0.01% 3317
2026
Q1
$14.1M Sell
145,288
-6,681
-4% -$681K ﹤0.01% 1741
2025
Q4
$15.3M Buy
151,969
+20,941
+16% +$2.06M ﹤0.01% 1633
2025
Q3
$11.3M Sell
131,028
-7,941
-6% -$628K ﹤0.01% 1819
2025
Q2
$10.6M Buy
138,969
+5,875
+4% +$430K ﹤0.01% 1822
2025
Q1
$9.44M Sell
133,094
-870
-0.6% -$68K ﹤0.01% 1852
2024
Q4
$10.5M Buy
+133,964
New +$12.5M ﹤0.01% 1808

Other funds holding NUVL

Raymond James Financial's NUVL Position: Q2 2026 in Review

Raymond James Financial reduced its Nuvalent (NUVL) stake by 86% in Q2 2026, selling an estimated $13.4M and leaving 20,584 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3317.

Raymond James Financial first reported a position in NUVL in Q4 2024 and has held it in 7 quarters since. The position peaked at $15.3M in Q4 2025. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Raymond James Financial held 20,584 shares of Nuvalent worth $2.54M as of Q2 2026.
  • Raymond James Financial sold 124,704 Nuvalent shares in Q2 2026, an estimated $13.4M.
  • Nuvalent made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3317 holding.
  • Raymond James Financial first reported a position in Nuvalent in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Nuvalent position peaked at $15.3M in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.